Elsevier,

Current Developments in Nutrition, Volume 7, November 2023

This paper concludes that it is imperative to identify effective, early treatments for Alzheimer's disease. Creatine is an important bioenergetic molecule, and the Creatine system is shown to be dysfunctional in the brain of individuals with Alzheimer's disease. Therefore, Ceatine may serve as a potential target for prevention and therapy and creatine monohydrate supplementation may be beneficial in Alzheimer's disease. To date, only rodent studies have investigated the use of creatine monohydrate as a treatment for Alzheimer's disease.. Thus, clinical trials investigating the effects of creatine monohydrateon cognition and creatine monohydrate’s mechanisms in humans with Alzheimer's disease as well as its potential as a strategy to prevent cognitive decline in those with normal cognition, are needed. There is much to be learned about CrM intervention and brain health in different life and disease phases.
This study highlights that pomegranate supplementation can be a promising source of protection against Alzheimer's disease.
Elsevier,

Principles and Practice of Pediatric Infectious Diseases (Sixth Edition)
2023, Pages 700-707.e2

This content aligns with Goal 3: Good Health and Wellbeing by emphasizing the predominantly outpatient care-based approach to the use of antiretroviral therapy (ART).
This content aligns with Goal 3: Good Health and Wellbeing by exploring the current tools that could eliminate HIV-AIDS as a public health threat through engagement in communities and expanding testing, implementing combined prevention for individuals at risk of HIV exposure, and providing optimal treatment to all positive cases.
Elsevier,

Viral Infections and Antiviral Therapies
2023, Pages 263-283

This content aligns with Goal 3: Good Health and Wellbeing by providing a comprehensive discussion on antiretroviral therapies.
The “contour smoothing” fractal analysis method can effectively examine cerebral hemispheres to detect and quantify age-related atrophic changes associated with normal or pathological aging. This method holds promise for clinical application in diagnosing neurodegenerative disorders, such as Alzheimer’s disease.
This study finds that pine nut peptide-zinc chelate improves Alzheimer's Disease (AD) in various ways which include (1) improving learning, memory, brain health, and gut balance in mice, and (2) treating cholinergic system changes, boosting cerebral antioxidants, and altering gut microbiota. Pine nut peptide-zinc chelate holds potential for AD therapy, requiring deeper mechanistic investigation.
This content advances UN SDG 3 (Good Health and Well-being) and 10 (Reduced Inequalities) by discussing the health disparity experienced by First Nations Australians experience compared to non-Indigenous Australians in the management of metabolic syndrome and its complications and how a multidisciplinary approach and involvement of Aboriginal healthcare practitioners is essential.
This Series paper supports SDG 3 by evaluating existing and emerging vaccines and vaccination campaigns against hepatitis B virus and other sexually transmitted infections, as well as other interventions such as PrEP for HIV
This article contributes to SDG 3 by developing predictive tools to improve clinical management of autoimmune hepatitis.

Pages